Fighting for FREEDOM

Could your patients be a part of the FREEDOM-3 trial for dcSSc?

As you know, currently there is no cure for dcSSc, and it’s usually managed with immunosuppressive medicines to minimize disease impact and development of major health complications.

Although these medicines are the standard of care for dcSSc, they can have limitations and are often not very effective—leaving patients still looking for alternative treatments for symptom relief.

Could your patients participate in the FREEDOM-3 trial?

To participate in the FREEDOM-3 clinical trial, eligible patients must be diagnosed with dcSSc. The main goal of this trial is to determine the safety, tolerability, and efficacy of an investigational cell therapy.

Models pictured are not actual participants
in the FREEDOM-3 trial.